Patent 9240043 was granted and assigned to Novartis on January, 2016 by the United States Patent and Trademark Office.
A method is described for the reproducible quantification of biomarker expression, including biomarker expression in a tissue sample. Methods and systems are described whereby reproducible scores for biomarker expression are obtained independent of instrument, its location, or operator.